TransMedics Group, Inc. (NASDAQ:TMDX – Free Report) CEO Waleed H. Hassanein sold 7,500 shares of the stock in a transaction dated Monday, July 3rd. The stock was sold at an average price of $82.51, for a total transaction of $618,825.00. Following the sale, the chief executive officer now owns 544,191 shares of the company’s stock, […]